Individualized thyrotropin suppression in patients with differentiated thyroid cancers / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 451-453, 2011.
Article
Dans Chinois
| WPRIM
| ID: wpr-416922
ABSTRACT
The epidemic characteristics of differentiated thyroid cancer(DTC)are changing, thyrotropin(TSH)suppressive therapy is also improving in recent years. The risks of recurrence and the death of patients, as well as the adverse effects of levothyroxine sodium treatment should be fully considered during thyroid hormone administration for patients of DTC. Hence, the degree of TSH suppression should be individualized in patients with DTC.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Endocrinology and Metabolism
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS